Skip to main content
. 2021 Oct 18;71(6):1531–1543. doi: 10.1007/s00262-021-03075-3

Fig. 3.

Fig. 3

A low neutrophil: lymphocyte (N:L) ratio correlates with survival. The median PFS (mPFS) was significantly longer in patients with a pre-treatment N:L ratio < 3. HR: hazard ratio for risk of progression. CI confidence interval